Copyright
©The Author(s) 2018.
World J Crit Care Med. Sep 7, 2018; 7(4): 46-51
Published online Sep 7, 2018. doi: 10.5492/wjccm.v7.i4.46
Published online Sep 7, 2018. doi: 10.5492/wjccm.v7.i4.46
Support or outcome variable | NIMV responders (n = 36) | NIMV non-responders (n = 6) | Total (n = 42) | P value |
Max delta P of NIMV (cmH2O) | 16 (6-26, IQR = 6.5) | 17.5 (10-30, IQR = 6) | 16.5 (6-30, IQR = 6) | 0.68 |
Max FIO2 of NIMV (%) | 40 (25-100, IQR = 22.5) | 42.5 (30-70, IQR = 10) | 40 (25-100, IQR = 15) | 0.84 |
Max PEEP of NIMV (cmH2O) | 6 (5-8, IQR = 2) | 5 (5-8, IQR = 2) | 6 (5-8, IQR = 2) | 0.37 |
Max rate of NIMV (breaths per minute) | 30 (20-70, IQR = 3.5) | 30 (20-60, IQR = 5) | 30 (20-70, IQR = 2) | 0.32 |
Time to max FIO2 (h) | 0 (0-119, IQR = 1.5) | 0 (0-29.5, IQR = 6) | 0 (0-119, IQR = 2) | 0.75 |
Time to max setting (h) | 1 (0-48, IQR = 9) | 3 (0-29.5, IQR = 20) | 1 (0-48, IQR = 10) | 0.8 |
Hospital length of stay (d) | 7 (3-30, IQR = 3.5) | 9 (4-14, IQR = 7) | 7.5 (3-30, IQR = 4) | 0.73 |
PICU length of stay (d) | 6 (3-30, IQR = 3) | 6.5 (3-14, IQR = 5) | 6 (3-30, IQR = 3) | 0.64 |
Total duration of NIMV (h) | 65 (5-240, IQR = 47.5) | 6.5 (0.5-30, IQR = 24) | 59.5 (0.5-240, IQR = 53) | 0.001 |
Total duration of all respiratory support (h) | 94.5 (28-254, IQR = 60) | 115 (65-230, IQR = 31.5) | 95.8 (28-254, IQR = 57) | 0.3 |
- Citation: Wang BC, Pei T, Lin CB, Guo R, Elashoff D, Lin JA, Pineda C. Clinical characteristics and outcomes associated with nasal intermittent mandatory ventilation in acute pediatric respiratory failure. World J Crit Care Med 2018; 7(4): 46-51
- URL: https://www.wjgnet.com/2220-3141/full/v7/i4/46.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v7.i4.46